Wearable Cardioverter Defibrillators Market - Top Companies and Manufacturers

Companies Dominating the Wearable Cardioverter Defibrillators Landscape

ZOLL Medical Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Element Science Inc.
Medtronic plc
Kestra Medical Technologies, Inc.
Abbott
Boston Scientific Corporation
LivaNova plc
Koninklijke Philips N.V.
Nihon Kohden Corporation
General Electric Company.

Browse Key Market Insights with Data Illustration:

Wearable Cardioverter Defibrillators Market Size & Share | Growth Trends 2036

In the News

Medtronic plc announced that it has obtained approval from the U.S. Food and Drug Administration (FDA) for Aurora EV-ICD MRI SureScan (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV MRI SureScan to offer the advantages of conventional, transvenous ICDs in terms of saving lives by providing anti-tachycardia pacing (ATP), backup (pause-prevention) pacing therapy, and life-saving defibrillation.
Abbott received approval from the U.S. Food and Drug Administration (FDA) for Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices with Bluetooth technology and a new patient smartphone app for better remote monitoring for patients with cardiac rhythm abnormalities.

Frequently Asked Questions (FAQ)

Rising incidence of heart attacks across the globe and the growing technological advancement in cardiology are the major factors driving the growth of the market.

The market size of Wearable Cardioverter Defibrillators is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024 â€“ 2036.

The major players in the market are ZOLL Medical Corporation, Element Science Inc., Medtronic plc, Kestra Medical Technologies, Inc., Abbott, Boston Scientific Corporation, LivaNova plc, Koninklijke Philips N.V., Nihon Kohden Corporation and General Electric Company., and others.

The peripartum cardiomyopathy segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

Wearable Cardioverter Defibrillators Market - Top Companies and Manufacturers

Companies Dominating the Wearable Cardioverter Defibrillators Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the wearable cardioverter defibrillators market?

What would be the CAGR of the wearable cardioverter defibrillators market over the forecast period?

Who are the major players dominating the wearable cardioverter defibrillators market?

Which segment captures the largest market size in the indication segment in the wearable cardioverter defibrillators market?

Which region will provide more business opportunities for the growth of the wearable cardioverter defibrillators market in the future?